Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type, By Product, By Application, and By Region

Description

The global phage therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of foodborne diseases, anti-biotic infections, and extensive research and development. Phages, also known as bacteriophages, are viruses that only kill and selectively target bacteria. They are the most common biological entities found in nature, effectively fighting, and destroying multi-drug-resistant bacteria. They are used to treat or stop bacterial infections in patients' bodies. The other factors supporting the market's growth are, the increasing application of bacteriophage across the food and beverage industry, increasing government investments, rising awareness among the masses, and technological advancements.

High Prevalence Rate of Foodborne Diseases and Anti-Biotic Infections

The rise in the prevalence rate of foodborne diseases and anti-biotic infections across the globe is expected to enhance the market's growth. Foodborne infections are caused by rotten food, as pathogenic bacteria and viruses are present in them. Bacteriophages are extremely specific to target bacteria. Its usage targets a specific bacterial species and significantly reduces off-target effects on the microbiome or human patient, as bacteriophages do not directly affect human cells. According to the WHO, in 2019, forecasted that about 600 million people will become ill and 420,000 will die because of contaminated food resulting in the loss of 33 million healthy life years. Also, according to the Centers for Disease Control and Prevention (CDC), in 2019, approximately 2 million people in the United States will contract an antibiotic-resistant infection, with at least 23,000 people dying every year.

Increasing Investment

Heavy investments to support phage therapy by the government is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government and lead companies across the globe are investing in clinical trials and R&D Activities, which is propelling the growth of the market. For instance, in 2016, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, was granted US$ 5 Mn for 24 research projects to develop advanced therapies such as bacteriophage therapy and others for the treatment of bacterial infections.

Emergence of e-Commerce

Emergence of e-Commerce is bolstering the growth of the market. Several biotech market players are starting to set up online pharmacies of bacteriophage preparations to make phages and phage therapies available across the globe. For instance, in 2020, Ridgeway, a Digital agency, launched a new e-Commerce website for Optibac probiotics, to build on customer compliance and repeat purchase of phage therapy supplements.

Market Segmentation

The global phage therapy market is segmented into bacteria type, products, application, and company. Based on bacteria type, the market is divided into salmonella, bacteriophage, streptococcus, E.coli, and others. Based on products, the market is divided into oral consumption, external consumption, and surgical treatment. Based on application, the market is segmented into human medicines, veterinary sciences, food & beverage, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of foodborne diseases and anti-biotic infections in the country.

Market Players

Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are some of the leading companies operating in the market.

Report Scope:

In this report, global phage therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Phage Therapy Market, By Bacterial Type:

Salmonella

Bacteriophage

Streptococcus

E.Coli

Others

Phage Therapy Market, By Products:

Oral Consumption

External Consumption

Surgical Treatment

Phage Therapy Market, By Application:

Human Medicines

Veterinary Sciences

Food & Beverage

Others

Phage Therapy Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Phage Therapy Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Product Code: 12984

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Phage Therapy Market

5. Voice of Customer

6. Clinical Trials Analysis

7. Global Phage Therapy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others)
- 7.2.2. By Product (Oral Consumption, External Consumption, Surgical Treatment)
- 7.2.3. By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others)
- 7.2.4. By Company (2021)
- 7.2.5. By Region
7.3. Market Map

8. North America Phage Therapy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Bacteria Type
- 8.2.2. By Product
- 8.2.3. By Application
- 8.2.4. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Phage Therapy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Bacteria Type
    - 8.3.1.2.2. By Product
    - 8.3.1.2.3. By Application
- 8.3.2. Mexico Phage Therapy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Bacteria Type
    - 8.3.2.2.2. By Product
    - 8.3.2.2.3. By Application
- 8.3.3. Canada Phage Therapy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Bacteria Type
    - 8.3.3.2.2. By Product
    - 8.3.3.2.3. By Application

9. Europe Phage Therapy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Bacteria Type
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By Country
9.3. Europe: Country Analysis
- 9.3.1. France Phage Therapy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Bacteria Type
    - 9.3.1.2.2. By Product
    - 9.3.1.2.3. By Application
- 9.3.2. Germany Phage Therapy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Bacteria Type
    - 9.3.2.2.2. By Product
    - 9.3.2.2.3. By Application
- 9.3.3. United Kingdom Phage Therapy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Bacteria Type
    - 9.3.3.2.2. By Product
    - 9.3.3.2.3. By Application
- 9.3.4. Italy Phage Therapy Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Bacteria Type
    - 9.3.4.2.2. By Product
    - 9.3.4.2.3. By Application
- 9.3.5. Spain Phage Therapy Market Outlook
  - 9.3.5.1. Market Size & Forecast
    - 9.3.5.1.1. By Value
  - 9.3.5.2. Market Share & Forecast
    - 9.3.5.2.1. By Bacteria Type
    - 9.3.5.2.2. By Product
    - 9.3.5.2.3. By Application

10. Asia-Pacific Phage Therapy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Bacteria Type
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By Country
10.3. Asia-Pacific: Country Analysis
- 10.3.1. China Phage Therapy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Bacteria Type
    - 10.3.1.2.2. By Product
    - 10.3.1.2.3. By Application
- 10.3.2. India Phage Therapy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Bacteria Type
    - 10.3.2.2.2. By Product
    - 10.3.2.2.3. By Application
- 10.3.3. Japan Phage Therapy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Bacteria Type
    - 10.3.3.2.2. By Product
    - 10.3.3.2.3. By Application
- 10.3.4. South Korea Phage Therapy Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Bacteria Type
    - 10.3.4.2.2. By Product
    - 10.3.4.2.3. By Application
- 10.3.5. Australia Phage Therapy Market Outlook
  - 10.3.5.1. Market Size & Forecast
    - 10.3.5.1.1. By Value
  - 10.3.5.2. Market Share & Forecast
    - 10.3.5.2.1. By Bacteria Type
    - 10.3.5.2.2. By Product
    - 10.3.5.2.3. By Application

11. South America Phage Therapy Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Bacteria Type
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By Country
11.3. South America: Country Analysis
- 11.3.1. Brazil Phage Therapy Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Bacteria Type
    - 11.3.1.2.2. By Product
    - 11.3.1.2.3. By Application
- 11.3.2. Argentina Phage Therapy Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Bacteria Type
    - 11.3.2.2.2. By Product
    - 11.3.2.2.3. By Application
- 11.3.3. Colombia Phage Therapy Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Bacteria Type
    - 11.3.3.2.2. By Product
    - 11.3.3.2.3. By Application

12. Middle East and Africa Phage Therapy Market Outlook

12.1. Market Size & Forecast
- 12.1.1. By Value
12.2. Market Share & Forecast
- 12.2.1. By Bacteria Type
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By Country
12.3. MEA: Country Analysis
- 12.3.1. South Africa Phage Therapy Market Outlook
  - 12.3.1.1. Market Size & Forecast
    - 12.3.1.1.1. By Value
  - 12.3.1.2. Market Share & Forecast
    - 12.3.1.2.1. By Bacteria Type
    - 12.3.1.2.2. By Product
    - 12.3.1.2.3. By Application
- 12.3.2. Saudi Arabia Phage Therapy Market Outlook
  - 12.3.2.1. Market Size & Forecast
    - 12.3.2.1.1. By Value
  - 12.3.2.2. Market Share & Forecast
    - 12.3.2.2.1. By Bacteria Type
    - 12.3.2.2.2. By Product
    - 12.3.2.2.3. By Application
- 12.3.3. UAE Phage Therapy Market Outlook
  - 12.3.3.1. Market Size & Forecast
    - 12.3.3.1.1. By Value
  - 12.3.3.2. Market Share & Forecast
    - 12.3.3.2.1. By Bacteria Type
    - 12.3.3.2.2. By Product
    - 12.3.3.2.3. By Application
- 12.3.4. Egypt Phage Therapy Market Outlook
  - 12.3.4.1. Market Size & Forecast
    - 12.3.4.1.1. By Value
  - 12.3.4.2. Market Share & Forecast
    - 12.3.4.2.1. By Bacteria Type
    - 12.3.4.2.2. By Product
    - 12.3.4.2.3. By Application
- 12.3.5. Turkey Phage Therapy Market Outlook
  - 12.3.5.1. Market Size & Forecast
    - 12.3.5.1.1. By Value
  - 12.3.5.2. Market Share & Forecast
    - 12.3.5.2.1. By Bacteria Type
    - 12.3.5.2.2. By Product
    - 12.3.5.2.3. By Application

13. Market Dynamics

13.1. Drivers
13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

15.1. Armata Pharmaceuticals, Inc.
15.2. iNtODEWORLD, Inc.
15.3. Phage International, Inc.
15.4. Fixed-Phage Limited
15.5. OCUS BIOSCIENCES, INC.
15.6. Intralytix, Inc
15.7. PhagoMed Biopharma GmbH
15.8. PHAGELUX, INC.
15.9. Pherecydes Pharma SADIR
15.10. Adaptive Phage Therapeutics Inc.